Insider · CIK 0001226961
Richard A Waldron
cfoofficer
Files at BCAB (BioAtla, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 28, 2026 | BCAB BioAtla, Inc. | FTax withholding Common Stock | -2,729 | $0.25 | $674 | 343,421 | Mar 2, 2026 |
| Nov 30, 2025 | BCAB BioAtla, Inc. | FTax withholding Common Stock | -2,371 | $0.90 | $2,143 | 346,150 | Dec 1, 2025 |
| Aug 31, 2025 | BCAB BioAtla, Inc. | FTax withholding Common Stock | -2,371 | $0.46 | $1,080 | 338,521 | Sep 2, 2025 |
| May 31, 2025 | BCAB BioAtla, Inc. | FTax withholding Common Stock | -2,371 | $0.41 | $970 | 340,892 | Jun 3, 2025 |
| Mar 11, 2025 | BCAB BioAtla, Inc. | AGrant or award Common Stock | +100,000 | $0.00 | $0 | 333,263 | Mar 13, 2025 |
| Feb 15, 2025 | BCAB BioAtla, Inc. | FTax withholding Common Stock | -10,887 | $0.46 | $5,008 | 233,263 | Feb 24, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.